Dawn Grimm, FNP

NPI: 1588157465
Total Payments
$1,923
2024 Payments
$1,055
Companies
29
Transactions
56
Medicare Patients
678
Medicare Billing
$52,255

Payment Breakdown by Category

Food & Beverage$1,359 (70.7%)
Education$564.08 (29.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,359 50 70.7%
Education $564.08 6 29.3%

Top Paying Companies

Company Total Records Latest Year
Incyte Corporation $329.22 7 $0 (2024)
Lilly USA, LLC $144.98 3 $0 (2024)
PFIZER INC. $122.94 2 $0 (2024)
Astellas Pharma US Inc $114.70 2 $0 (2024)
E.R. Squibb & Sons, L.L.C. $104.58 1 $0 (2024)
Gilead Sciences, Inc. $97.78 2 $0 (2024)
Novartis Pharmaceuticals Corporation $96.31 4 $0 (2024)
Mirati Therapeutics, Inc. $92.67 1 $0 (2024)
AstraZeneca Pharmaceuticals LP $84.95 1 $0 (2023)
Eisai Inc. $72.02 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,055 23 Incyte Corporation ($143.22)
2023 $801.27 29 Incyte Corporation ($186.00)
2022 $67.12 4 Merck Sharp & Dohme LLC ($21.19)

All Payment Transactions

56 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/19/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $21.88 General
Category: Hematology/Oncology
09/09/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $104.58 General
06/24/2024 Gilead Sciences, Inc. Trodelvy (Drug) Education In-kind items and services $74.99 General
Category: ONC
06/13/2024 Incyte Corporation Education Cash or cash equivalent $99.99 General
06/06/2024 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Food and Beverage In-kind items and services $39.11 General
Category: HEMATOLOGY/ONCOLOGY
06/05/2024 ABBVIE INC. EPKINLY (Drug), IMBRUVICA Food and Beverage In-kind items and services $25.20 General
Category: ONCOLOGY
05/30/2024 PFIZER INC. Education In-kind items and services $99.99 General
05/23/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $27.79 General
Category: Oncology
05/22/2024 ABBVIE INC. IMBRUVICA (Drug), EPKINLY Food and Beverage In-kind items and services $27.15 General
Category: ONCOLOGY
05/06/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $21.35 General
Category: Hematology/Oncology
04/29/2024 Lilly USA, LLC JAYPIRCA (Drug) Food and Beverage In-kind items and services $21.07 General
Category: Oncology
04/18/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $20.95 General
Category: Oncology
04/10/2024 Apellis Pharmaceuticals, Inc. Empaveli (Drug) Food and Beverage In-kind items and services $18.14 General
Category: Hematology
04/03/2024 Astellas Pharma US Inc Padcev (Drug) Food and Beverage In-kind items and services $15.70 General
Category: Oncology
03/27/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $23.85 General
Category: Oncology
03/11/2024 Lilly USA, LLC VERZENIO (Drug) Education In-kind items and services $105.16 General
Category: Oncology
03/07/2024 SERVIER PHARMACEUTICALS LLC Tibsovo (Drug) Food and Beverage In-kind items and services $22.75 General
Category: Oncology
02/15/2024 Pharmacosmos Therapeutics Inc. COSELA (Drug) Food and Beverage In-kind items and services $24.62 General
Category: HEMATOLOGY
02/14/2024 Astellas Pharma US Inc Education In-kind items and services $99.00 General
02/13/2024 Mirati Therapeutics, Inc. KRAZATI (Drug) Food and Beverage Cash or cash equivalent $92.67 General
Category: Oncology
01/11/2024 Genentech USA, Inc. Lunsumio (Biological) Food and Beverage In-kind items and services $18.28 General
Category: BioOncology
01/05/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $27.95 General
Category: ONCOLOGY
01/03/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $22.79 General
12/20/2023 Eisai Inc. Lenvima (Drug) Food and Beverage Cash or cash equivalent $24.46 General
Category: Oncology
12/07/2023 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $124.99 General
Category: Hematology/Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 119 194 $27,415 $9,638
2022 1 26 49 $15,043 $5,627
2021 6 151 167 $30,340 $10,363
2020 7 382 417 $79,419 $26,626
Total Patients
678
Total Services
827
Medicare Billing
$52,255
Procedure Codes
20

All Medicare Procedures & Services

20 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 23 37 $11,359 $4,099 36.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 23 34 $7,786 $2,999 38.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 24 30 $4,710 $1,788 38.0%
80053 Blood test, comprehensive group of blood chemicals Office 2023 17 32 $1,760 $304.56 17.3%
36415 Insertion of needle into vein for collection of blood sample Office 2023 17 32 $640.00 $246.51 38.5%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 15 29 $1,160 $201.10 17.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 26 49 $15,043 $5,627 37.4%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2021 37 38 $8,246 $2,697 32.7%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 20 20 $5,860 $1,974 33.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 12 14 $4,298 $1,831 42.6%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 40 48 $4,032 $1,321 32.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 20 25 $3,900 $1,298 33.3%
99497 Advance care planning by the physician or other qualified health care professional, first 30 minutes Facility 2021 22 22 $4,004 $1,243 31.1%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 65 66 $19,338 $6,573 34.0%
99221 Initial hospital inpatient care, typically 30 minutes per day Facility 2020 85 88 $19,096 $6,565 34.4%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 106 130 $10,920 $3,742 34.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 23 23 $9,959 $3,247 32.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 41 44 $6,864 $2,320 33.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 28 30 $6,690 $2,124 31.7%
99497 Advance care planning by the physician or other qualified health care professional Facility 2020 34 36 $6,552 $2,056 31.4%

About Dawn Grimm, FNP

Dawn Grimm, FNP is a Family healthcare provider based in Lisle, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2018. The National Provider Identifier (NPI) number assigned to this provider is 1588157465.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dawn Grimm, FNP has received a total of $1,923 in payments from pharmaceutical and medical device companies, with $1,055 received in 2024. These payments were reported across 56 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($1,359).

As a Medicare-enrolled provider, Grimm has provided services to 678 Medicare beneficiaries, totaling 827 services with total Medicare billing of $52,255. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Lisle, IL
  • Active Since 06/14/2018
  • Last Updated 07/11/2023
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1588157465

Products in Payments

  • JAKAFI (Drug) $229.23
  • VERZENIO (Drug) $105.16
  • KRAZATI (Drug) $92.67
  • CALQUENCE (Drug) $84.95
  • Trodelvy (Drug) $74.99
  • Lenvima (Drug) $72.02
  • IMBRUVICA (Drug) $68.74
  • KEYTRUDA (Biological) $59.91
  • PLUVICTO (Drug) $50.61
  • TABRECTA (Drug) $45.70
  • DARZALEX (Biological) $39.95
  • ZEPZELCA (Drug) $39.11
  • Xermelo (Drug) $36.38
  • Doptelet (Drug) $35.97
  • Nubeqa (Drug) $33.85
  • LIBTAYO (Biological) $31.36
  • Enhertu (Drug) $27.95
  • EPKINLY (Drug) $25.20
  • ULTOMIRIS (Biological) $25.13
  • COSELA (Drug) $24.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Lisle